Nivolumab and ipilimumab in combination for lung cancer

Update Il y a 5 ans
Reference: U1111-1184-3746

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To characterize the safety of nivolumab administered as a flat dose in combination with weight-based ipilimumab dosing in Cohorts A and B.


Inclusion criteria

  • non-small cell lung cancer